TVRD

Tvardi Therapeutics, Inc. - Common Stock (TVRD)

About Tvardi Therapeutics, Inc. - Common Stock (TVRD)

Tvardi Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the development of novel, oral small molecule therapies targeting STAT3 to treat fibrosis-driven diseases with significant unmet need. The company was founded in 2017 and is headquartered in Sugar Land, TX.

Details

Daily high

$1.28

Daily low

$1.13

Price at open

$1.25

52 Week High

$43.65

52 Week Low

$0.93

Market cap

16.5M

Dividend yield

Volume

313,811

Avg. volume

232,957

P/E ratio

-.45

Tvardi Therapeutics, Inc. - Common Stock News